These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34684447)

  • 21. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
    Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
    Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism.
    Mori J; Oudit GY; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E43-E47. PubMed ID: 32469255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 pandemic, coronaviruses, and diabetes mellitus.
    Muniyappa R; Gubbi S
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E736-E741. PubMed ID: 32228322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.
    Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP
    FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Obesity, inflammation and COVID-19: preventive interest of ketogenic diet?].
    Charlot A; Boumiza R; Roux M; Zoll J
    Biol Aujourdhui; 2021; 215(1-2):63-72. PubMed ID: 34397376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 and Obesity: "CoVesity"-a Pandemic Within a Pandemic.
    Zakka K; Chidambaram S; Mansour S; Mahawar K; Salminen P; Almino R; Schauer P; Kinross J; Purkayastha S;
    Obes Surg; 2021 Apr; 31(4):1745-1754. PubMed ID: 33479921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 and Obesity: Overlapping of Two Pandemics.
    Gammone MA; D'Orazio N
    Obes Facts; 2021; 14(6):579-585. PubMed ID: 34569546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Weight of Obesity in Immunity from Influenza to COVID-19.
    Andrade FB; Gualberto A; Rezende C; Percegoni N; Gameiro J; Hottz ED
    Front Cell Infect Microbiol; 2021; 11():638852. PubMed ID: 33816341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
    Méry G; Epaulard O; Borel AL; Toussaint B; Le Gouellec A
    Front Immunol; 2020; 11():1714. PubMed ID: 32793244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections.
    Hulme KD; Noye EC; Short KR; Labzin LI
    Front Immunol; 2021; 12():770066. PubMed ID: 34777390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes and COVID-19: Population Impact 18 Months Into the Pandemic.
    Gregg EW; Sophiea MK; Weldegiorgis M
    Diabetes Care; 2021 Sep; 44(9):1916-1923. PubMed ID: 34244333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York.
    Palaiodimos L; Kokkinidis DG; Li W; Karamanis D; Ognibene J; Arora S; Southern WN; Mantzoros CS
    Metabolism; 2020 Jul; 108():154262. PubMed ID: 32422233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excess Body Mass-A Factor Leading to the Deterioration of COVID-19 and Its Complications-A Narrative Review.
    Gryczyńska W; Litvinov N; Bitew B; Bartosz Z; Kośmider W; Bogdański P; Skrypnik D
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When Pandemics Collide: the Interplay of Obesity and COVID-19.
    Mundi MS; Patel JJ; Mohamed Elfadil O; Patel J; Patel I; Nanda S; Hurt RT
    Curr Gastroenterol Rep; 2021 Nov; 23(12):26. PubMed ID: 34735631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2-host dynamics: Increased risk of adverse outcomes of COVID-19 in obesity.
    Yadav R; Aggarwal S; Singh A
    Diabetes Metab Syndr; 2020; 14(5):1355-1360. PubMed ID: 32755835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury.
    Lasbleiz A; Gaborit B; Soghomonian A; Bartoli A; Ancel P; Jacquier A; Dutour A
    Front Endocrinol (Lausanne); 2021; 12():726967. PubMed ID: 34484128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
    Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.
    Seltzer S
    Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.